Clinical Trial

Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 18, 2025 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
The goals of this project are to build an experimental tool to dissect out in vivo pancreatic beta cell mass (BCM) and beta cell function (BCF) and to assess for the first time these two determinants of beta cell functional mass (BCFxM) in obesity and in various stages of type 1 and type 2 diabetes mellitus.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-12-20; most recent amendment 2025-03-14.
Trial Details
NCT Number NCT05662189
Lead Sponsor Azienda Ospedaliero-Universitaria di Parma
Collaborators: University of Parma
Conditions Type1diabetes, Type2diabetes, Pre Diabetes, Hyperinsulinism
Enrollment 70 participants
Start Date 2022-03-15
Primary Completion 2025-07 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-18